Orphan Drugs

Orphan pharmaceuticals are prescription medications used to treat rare illnesses or disorders that are meant to be treated, prevented from occurring, or diagnosed. They are referred to as "orphan medications" due to the small size of their market. A illness is considered an orphan if it affects fewer than 200,000 persons nationally. The majority of orphan diseases have a genetic basis. Orphan diseases are rare and could impact one in every 15 people worldwide.

 

    Related Conference of Orphan Drugs

    November 21-22, 2024

    8th International Conference on Rare Diseases

    Dubai, UAE
    November 21-22, 2024

    7th Pathology and Infectious Disease Conference

    Dubai, UAE
    November 28-29, 2024

    20th World Congress on Infection Prevention and Control

    Paris, France
    March 17-18, 2025

    12th International Congress on Infectious Diseases

    Berlin, Germany
    June 02-03, 2025

    14th World Congress on Rare Diseases and Orphan Drugs

    Amsterdam, Netherlands
    June 02-03, 2025

    17th Euro-Global Conference on Infectious Diseases

    Amsterdam, Netherlands

    Orphan Drugs Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in